Award
Award 75N92020C00022 — AEGIS SCIENCES CORPORATION
- Awarded to
- AEGIS SCIENCES CORPORATION
- Agency
- Department of Health and Human Services
- Estimated value
- $17,982,063
AEGIS SCIENCES RAPID DEVELOPMENT OF SARS-COV-2 TEST CAPACITY RAPID ACCELERATION OF DIAGNOSTICS (RADX) PROGRAM: ATP PROJECT #6822 AEGIS SCIENCES CORP.
Key dates
- Award date
- August 27, 2020
- Performance start
- August 27, 2020
- Performance end
- August 26, 2022
Who is this buyer
Organization
Buying history
- Records30 total
- Opportunities / awards0 / 11
- Value range$0 – $17,982,063
- ActiveAugust 4, 2026 – October 24, 2026
What they buy
- Clinical (29)
- Administrative (1)
Set-asides used
- No Set aside used (3)
Who holds their work today
- AEGIS SCIENCES CORPORATION1 win · $17,982,063 · last August 27, 2020
- GEORGETOWN UNIVERSITY1 win · $173,951 · last May 2, 2023
- THE BROAD INSTITUTE, INC1 win · $161,250 · last July 7, 2021
- QUEST DIAGNOSTICS INCORPORATED2 wins · $156,175 · last January 5, 2026
- GENOMIC TESTING COOPERATIVE, LCA2 wins · $48,000 · last January 20, 2026
View source document →
Source link on usaspending.
Source record
- Buyer type
- Federal
- Jurisdiction
- Federal (US)
- Category
- Clinical
- Set-aside
- Not stated
- NAICS
- 621511
- PSC
- Q301